Evolve Transition Infrastructure LP: Nasdaq/NYSE listing notice — NYSE American lifts trading suspension on Evolve common units; trading resumes July 31

Evolve Transition Infrastructure LP

NYSE withdrew delisting determination for low selling price deficiency under Section 1003(f)(v).
Common units (SNMP) will resume trading on NYSE American at market open July 31, 2023.
Partnership remains subject to previously disclosed plan to regain compliance with Sections 1003(a)(i) and (a)(ii) by June 6, 2024.
Failure to meet compliance by June 6, 2024, could lead to renewed delisting proceedings.
Hearing before Listing Qualifications Panel scheduled for August 8, 2023 has been cancelled.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Evolve Transition Infrastructure LP received a nyse_american compliance regained notice regarding minimum bid price (rules 1003(f)(v)).

Exchange: nyse american
Notice: compliance regained
Deficiency: minimum bid price
Rules: 1003(f)(v)

Exact text from the filing

July 25, 2023, the Partnership received notice from the NYSE informing the Partnership that it has resolved the continued listing deficiency with respect to low selling price as described in Section 1003(f)(v) of the Company Guide. As a result, the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading suspension on the Common Units on the NYSE. Accordingly, the August 8, 2023 hearing before the Panel has been cancelled. The Common Units will commence trading on the NYSE at market open on Monday, July 31, 2023 under the symbol “SNMP.” The Partnership

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001362705-23-000091

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.